QigongQRENCT07294443
Qigong Relaxation Exercise
A study testing Qigong relaxation exercises and Ongoing treatment in people with Qigong and Anxiety, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
Trial summary
Objective: This study was conducted to examine the effect of Qigong relaxation exercises applied in a psychiatric clinic on the anxiety and depression levels of patients diagnosed with depression. Design: This study was designed as a single-blind, randomized controlled trial. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Qigong, Anxiety, Depression
- What is being tested?
- Qigong relaxation exercises and Ongoing treatment
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Mar 2025to 1 Sep 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- The patient is literate
- No communication barriers
- The patient is receiving inpatient treatment at a psychiatric clinic
- The patient has been diagnosed with depression
- The patient is over 18 years of age
- The patient is oriented to the service (at least 24 hours have passed since admission)
- The patient regularly participates in Qigong practice
Who cannot join
- The patient has communication difficulties
- The patient has acute psychotic symptoms
- The patient is receiving anxiolytic treatment
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Health Sciences University
Istanbul, Üsküdar - Selimiye, 34668
About this study
Official title: The Effect of Qigong Relaxation Exercise on Anxiety and Depression Levels in Individuals Diagnosed With Depression Hospitalized in a Psychiatric Clinic
Objective: This study was conducted to examine the effect of Qigong relaxation exercises applied in a psychiatric clinic on the anxiety and depression levels of patients diagnosed with depression.
Design: This study was designed as a single-blind, randomized controlled trial. Research Hypotheses H1: State anxiety levels are lower in patients who perform Qigong exercises than in those who do not.
Read more
H2: Depression levels are lower in patients who perform Qigong exercises than in those who do not.
The study population consisted of 140 individuals aged 18 years and older diagnosed with depression who were hospitalized at a private psychiatric hospital in Turkey between March 1 and September 1, 2025. In the sample selection, the STAI-I and Beck Depression Scale were administered to the patients by the researchers. Since differences in anxiety and depression levels would affect group homogeneity, patients who scored below 35 on the STAI-I (mild and moderate levels) and between 17 and 30 on the Beck Depression Scale constituted the study sample. The study sample consisted of 70 patients.
- Conditions
- Qigong, Anxiety, Depression, Psychiatric Disorders, Relaxation
- Being tested
- Qigong relaxation exercises, Ongoing treatment
- Medical subject headings
- Anxiety Disorders, Depression, Mental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Qigong relaxation exercisesOther
Qigong relaxation exercise is a type of exercise consisting of graceful body movements and relaxation, performed in harmony with breathing and meditation, aimed at relaxing the body and mind, reducing stress, diverting attention away from negative thoughts, accelerating blood flow, and improving emotions.
Ongoing treatmentOther
The control group's ongoing treatment continued.
| Study group | Role | What they receive |
|---|---|---|
| QRE | Experimental | Not described Receives: Other: Qigong relaxation exercises |
| Control group | Active comparator | Not described Receives: Other: Ongoing treatment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Beck Depression Scale
Beck Depression Scale: The Beck Depression Scale was used to measure the level and severity of depressive symptoms. The Beck Depression Scale, which underwent a Turkish validity and reliability study by Hisli in 1988, is a depression rating scale consisting of 21 questions. Individuals mark the statement that best describes how they have felt over the past 15 days, and the total score is calculated by summing the points (0-3) obtained from each response. According to the corresponding score ranges, the scale is evaluated as follows: 1-10 is normal, 11-16 is moderate mood disorder, 17-20 is clinical depression, 21-30 is moderate depression, 31-40 is severe depression, and 41-63 is major depression.
Measured: 6 weeks
State-Trait Anxiety Inventory
This scale was developed by Spielberger et al. (1983), and its validity and reliability in Turkish were established by Öner and Le Compte (1985). The scale consists of two parts: the State Anxiety Scale (STAI-I) and the Trait Anxiety Scale (STAI-II). STAI-I examines how an individual feels at a specific time and under specific conditions, while STAI-II determines how an individual feels independently of the situation and conditions they are in. STAI-I form, which consists of 20 statements, was used to measure state anxiety. Respondents rated their level of anxiety on a 4-point (1- 4) intensity scale from not at all tovery much so.
Measured: 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Dec 2025
- Study start1 Mar 2025
- Primary completion1 Sep 2025
- Study completion1 Sep 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for QigongStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- Saglik Bilimleri Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aydan Akkurt Yalçıntürk, Saglik Bilimleri Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07294443
- Sponsor's protocol ID
- 61351342
- Acronym
- QRE
- Status last verified
- Dec 2025
- First submitted
- 8 Dec 2025
- Last updated
- 19 Dec 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Qigong Relaxation Exercise on Anxiety and Depression Levels in Individuals Diagnosed With Depression Hospitalized in a Psychiatric Clinic
- ClinicalTrials.gov ID
- NCT07294443
- Acronym / sponsor ID
- QRE / 61351342
- Conditions
- Qigong, Anxiety, Depression, Psychiatric Disorders, Relaxation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- Saglik Bilimleri UniversitesiUniversity, hospital or other
- Study start
- 1 Mar 2025 (actual)
- Primary completion
- 1 Sep 2025 (actual)
- Study completion
- 1 Sep 2025 (actual)
- First posted
- 19 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Objective: This study was conducted to examine the effect of Qigong relaxation exercises applied in a psychiatric clinic on the anxiety and depression levels of patients diagnosed with depression.
Design: This study was designed as a single-blind, randomized controlled trial. Research Hypotheses H1: State anxiety levels are lower in patients who perform Qigong exercises than in those who do not.
H2: Depression levels are lower in patients who perform Qigong exercises than in those who do not.
The study population consisted of 140 individuals aged 18 years and older diagnosed with depression who were hospitalized at a private psychiatric hospital in Turkey between March 1 and September 1, 2025. In the sample selection, the STAI-I and Beck Depression Scale were administered to the patients by the researchers. Since differences in anxiety and depression levels would affect group homogeneity, patients who scored below 35 on the STAI-I (mild and moderate levels) and between 17 and 30 on the Beck Depression Scale constituted the study sample. The study sample consisted of 70 patients.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| QRE | Experimental | Other: Qigong relaxation exercises |
| Control group | Active comparator | Other: Ongoing treatment |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- The patient is literate
- No communication barriers
- The patient is receiving inpatient treatment at a psychiatric clinic
- The patient has been diagnosed with depression
- The patient is over 18 years of age
Key exclusion criteria (3 listed)
- The patient has communication difficulties
- The patient has acute psychotic symptoms
- The patient is receiving anxiolytic treatment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Qigong relaxation exercisesQigong relaxation exercise is a type of exercise consisting of graceful body movements and relaxation, performed in harmony with breathing and meditation, aimed at relaxing the body and mind, reducing stress, diverting attention away from negative thoughts, accelerating blood flow, and improving emotions. | Other | QRE |
| Ongoing treatmentThe control group's ongoing treatment continued. | Other | Control group |
Primary outcome
Beck Depression Scale
Time frame: 6 weeks
Beck Depression Scale: The Beck Depression Scale was used to measure the level and severity of depressive symptoms. The Beck Depression Scale, which underwent a Turkish validity and reliability study by Hisli in 1988, is a depression rating scale consisting of 21 questions. Individuals mark the statement that best describes how they have felt over the past 15 days, and the total score is calculated by summing the points (0-3) obtained from each response. According to the corresponding score ranges, the scale is evaluated as follows: 1-10 is normal, 11-16 is moderate mood disorder, 17-20 is clinical depression, 21-30 is moderate depression, 31-40 is severe depression, and 41-63 is major depression.
State-Trait Anxiety Inventory
Time frame: 6 weeks
This scale was developed by Spielberger et al. (1983), and its validity and reliability in Turkish were established by Öner and Le Compte (1985). The scale consists of two parts: the State Anxiety Scale (STAI-I) and the Trait Anxiety Scale (STAI-II). STAI-I examines how an individual feels at a specific time and under specific conditions, while STAI-II determines how an individual feels independently of the situation and conditions they are in. STAI-I form, which consists of 20 statements, was used to measure state anxiety. Respondents rated their level of anxiety on a 4-point (1- 4) intensity scale from not at all tovery much so.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Dec 2025.
- Individual participant dataSharing planned: No
Related trials for Qigong
Not yet recruiting
Effects of Tele-rehabilitation-Guided Qigong on Children and Adolescents With Asthma
Asthma Childhood
Recruiting
Feasibility of Identifying Brain Mechanisms of Qigong and Behavioral Outcomes After Qigong Practice in People With Chronic Low Back Pain
Low Back Pain
Recruiting
Stress Management and Meditative Movements for Asian Americans With Depression and Physical Symptoms
Depression / Major Depressive Disorder, Mental Health (Depression)
Active, not recruiting
Neurophysiological RCT of Qigong in Elderly With Depression
Depression
Not yet recruiting
Qigong Intervention for Fibromyalgia
Fibromyalgia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Qigong relaxation exercises and Ongoing treatment in people with Qigong and Anxiety, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Beck Depression Scale (time frame: 6 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2025.